CASI Pharmaceuticals
Stock Forecast, Prediction & Price Target
CASI Pharmaceuticals Financial Estimates
CASI Pharmaceuticals Revenue Estimates
CASI Pharmaceuticals EBITDA Estimates
CASI Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $30.16M N/A | $43.10M 42.88% | $33.87M -21.40% | Avg: $46.47M Low: $46.47M High: $46.47M avg. 37.18% | Avg: $70.35M Low: $70.35M High: $70.35M avg. 51.36% | Avg: $89.46M Low: $89.46M High: $89.46M avg. 27.16% | Avg: $108.07M Low: $108.07M High: $108.07M avg. 20.80% |
Net Income
% change YoY
| $-37.77M N/A | $-39.41M -4.33% | $-26.93M 31.64% | Avg: $-33.27M Low: $-28.45M High: $-28.45M avg. -23.52% | Avg: $-28.39M Low: $-23.38M High: $-23.38M avg. 14.66% | Avg: $-21.64M Low: $-21.64M High: $-21.64M avg. 23.77% | Avg: $-18.16M Low: $-18.16M High: $-18.16M avg. 16.04% |
EBITDA
% change YoY
| $-32.02M N/A | $-7.63M 76.16% | $-21.53M -182.18% | Avg: $-37.18M Low: $-37.18M High: $-37.18M avg. -72.65% | Avg: $-56.29M Low: $-56.29M High: $-56.29M avg. -51.36% | Avg: $-71.58M Low: $-71.58M High: $-71.58M avg. -27.16% | Avg: $-86.47M Low: $-86.47M High: $-86.47M avg. -20.80% |
EPS
% change YoY
| -$2.78 N/A | -$2.89 -3.95% | -$2.02 30.10% | Avg: -$2.13 Low: -$2.13 High: -$2.13 avg. -5.44% | Avg: -$1.75 Low: -$1.75 High: -$1.75 avg. 17.84% | Avg: -$1.62 Low: -$1.62 High: -$1.62 avg. 7.42% | Avg: -$1.36 Low: -$1.36 High: -$1.36 avg. 16.04% |
Operating Expenses
% change YoY
| $52.89M N/A | $53.77M 1.65% | $45.13M -16.06% | Avg: $116.83M Low: $116.83M High: $116.83M avg. 158.88% | Avg: $176.85M Low: $176.85M High: $176.85M avg. 51.36% | Avg: $224.90M Low: $224.90M High: $224.90M avg. 27.16% | Avg: $271.68M Low: $271.68M High: $271.68M avg. 20.80% |
FAQ
What is CASI Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 7.74% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -28.45M, average is -33.27M and high is -28.45M.
What is CASI Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 34.13% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $46.47M, average is $46.47M and high is $46.47M.
What is CASI Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 8.96% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.13, average is -$2.13 and high is $-2.13.
What is the best performing analyst?
In the last twelve months analysts have been covering CASI Pharmaceuticals stock. The most successful analyst is Sean Lee.